Similar articles for PMID: 19184081

Year	Number of Results
2000	10
2001	6
2002	5
2003	10
2004	12
2005	5
2006	10
2007	6
2008	13
2009	11
2010	8
2011	5
2012	9
2013	9
2014	11
2016	3
2017	4
2018	4
2020	2
2021	4
2022	10
2023	3
2024	0

1

Efficacy and safety of latanoprost in eyes with uveitic glaucoma.

Markomichelakis NN, Kostakou A, Halkiadakis I, Chalkidou S, Papakonstantinou D, Georgopoulos G. Markomichelakis NN, et al. Graefes Arch Clin Exp Ophthalmol. 2009 Jun;247(6):775-80. doi: 10.1007/s00417-009-1036-3. Epub 2009 Jan 28. Graefes Arch Clin Exp Ophthalmol. 2009. PMID: 19184081 Clinical Trial.

2

Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.

Fechtner RD, Airaksinen PJ, Getson AJ, Lines CR, Adamsons IA; COSOPT versus XALATAN Study Groups. Fechtner RD, et al. Acta Ophthalmol Scand. 2004 Feb;82(1):42-8. doi: 10.1046/j.1600-0420.2004.0205.x. Acta Ophthalmol Scand. 2004. PMID: 14982045 Free article. Clinical Trial.

3

A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma.

Parmaksiz S, Yüksel N, Karabas VL, Ozkan B, Demirci G, Caglar Y. Parmaksiz S, et al. Eur J Ophthalmol. 2006 Jan-Feb;16(1):73-80. Eur J Ophthalmol. 2006. PMID: 16496249 Clinical Trial.

4

24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy.

Konstas AG, Boboridis KG, Kapis P, Marinopoulos K, Voudouragkaki IC, Panayiotou D, Mikropoulos DG, Pagkalidou E, Haidich AB, Katsanos A, Quaranta L. Konstas AG, et al. Adv Ther. 2017 Jan;34(1):221-235. doi: 10.1007/s12325-016-0448-9. Epub 2016 Dec 2. Adv Ther. 2017. PMID: 27913991 Free PMC article. Clinical Trial.

5

Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America.

Susanna R Jr, Sheu WP; Latin American Glaucoma Society. Susanna R Jr, et al. Clin Ther. 2004 May;26(5):755-68. doi: 10.1016/s0149-2918(04)90075-6. Clin Ther. 2004. PMID: 15220019 Clinical Trial.

6

Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.

Lesk MR, Koulis T, Sampalis F, Sampalis JS, Bastien NR. Lesk MR, et al. Ann Pharmacother. 2008 Apr;42(4):498-504. doi: 10.1345/aph.1K565. Epub 2008 Mar 25. Ann Pharmacother. 2008. PMID: 18364402 Clinical Trial.

7

Efficacy and tolerability of latanoprost compared to dorzolamide combined with timolol in the treatment of patients with elevated intraocular pressure: a meta-analysis of randomized, controlled trials.

Cheng JW, Xi GL, Wei RL, Cai JP, Li Y. Cheng JW, et al. J Ocul Pharmacol Ther. 2009 Feb;25(1):55-64. doi: 10.1089/jop.2008.0080. J Ocul Pharmacol Ther. 2009. PMID: 19232016

8

Efficacy of the dorzolamide/timolol fixed combination versus latanoprost in the treatment of ocular hypertension or glaucoma: combined analysis of pooled data from two large randomized observer and patient-masked studies.

Fechtner RD, McCarroll KA, Lines CR, Adamsons IA. Fechtner RD, et al. J Ocul Pharmacol Ther. 2005 Jun;21(3):242-9. doi: 10.1089/jop.2005.21.242. J Ocul Pharmacol Ther. 2005. PMID: 15969642 Clinical Trial.

9

Comparison of the 24-hour intraocular pressure-lowering effects of latanoprost and dorzolamide/timolol fixed combination after 2 and 6 months of treatment.

Konstas AG, Kozobolis VP, Tsironi S, Makridaki I, Efremova R, Stewart WC. Konstas AG, et al. Ophthalmology. 2008 Jan;115(1):99-103. doi: 10.1016/j.ophtha.2007.03.007. Ophthalmology. 2008. PMID: 18166407 Clinical Trial.

10

Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.

García Sanchez J. García Sanchez J. Eur J Ophthalmol. 2000 Jul-Sep;10(3):198-204. Eur J Ophthalmol. 2000. PMID: 11071026 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

147 results

Results by year